osteolabs Publishes First Real-World Evidence Data from Close to 3, 000 OsteoTest Patient Samples
“We are very excited about the results from this collaborative [...]
Genprex Announces Positive Clinical Study Updates from Acclaim-1 and Acclaim-3 Phase 1/2 Clinical Trials in Lung Cancer
Genprex notes the patients in the Company’s lung cancer clinical [...]
Aethlon Medical Receives Second Ethics Committee Approval for Hemopurifier Cancer Trial
The Hemopurifier Cancer Trial will be conducted by Dr. Marco [...]
New Studies Validate the Value of Brainomix AI Technology Across US Stroke Networks
The latest research, in collaboration with the Mayo Clinic, West [...]
Trial Approval for New Pacemaker Aiming to Boost Recovery in Heart Failure
The system has shown a remarkable ability to boost performance [...]
TCBP Announces Dosing of 6th Patient in ACHIEVE Study in Patients with Acute Myeloid Leukemia
The ACHIEVE Study UK clinical trial is an open-label, phase [...]
Blood Filtration Offers Hope in the Fight Against Pancreatic Cancer
In a groundbreaking advancement of a novel cancer treatment, researchers [...]
Mabwell Receives NMPA Approval for Clinical Trial of Novel Nectin-4 Targeting ADC in TNBC
The study includes two cohorts: Cohort A will enroll patients [...]
Phage-Derived Enzyme Targets E. faecalis Biofilms to Mitigate Acute Graft-Versus-Host Disease
In a recent study published in the journal Nature, our [...]
OSE Immunotherapeutics Announces Publication of Preclinical Efficacy Results with Lusvertikimab in Acute Lymphoblastic Leukemia in the Journal ‘Blood’
Nicolas Poirier, Chief Executive Officer of OSE Immunotherapeutics, concludes: “We [...]